In August 2016, a letter was sent to relevant healthcare professionals to inform them of the outcome of a review of the
(Zydelig▼), including the risk of infection.
See also a Drug Safety Update article on the outcome of the safety review.
Article citation: Drug Safety Update volume 10 issue 2, September 2016: 4.
Published 15 September 2016